likely due to increased thrombosis risk in ANEXA-I trial
IMHO the best strategy is to keep this off your hospital's formulary (thereby avoiding endless circular debates about Adnexxa vs PCC)
firstwordpharma.com/story/5921956 #EMIMCC
likely due to increased thrombosis risk in ANEXA-I trial
IMHO the best strategy is to keep this off your hospital's formulary (thereby avoiding endless circular debates about Adnexxa vs PCC)
firstwordpharma.com/story/5921956 #EMIMCC
criticalcarereviews.com/latest-evide...
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2024
criticalcarereviews.com/latest-evide...
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2024